Comparison Overview

Medacta Germany

VS

STERIS

Medacta Germany

Jahnstraße 86, Göppingen, Baden-Württemberg 73037, DE
Last Update: 2025-03-16 (UTC)
Between 750 and 799

Medacta Germany ist eine Niederlassung von Medacta International, einem Unternehmen, das sich auf das Design, die Produktion und den Vertrieb von innovativen orthopädischen Produkten sowie auf die Entwicklung von begleitenden Operationstechniken spezialisiert hat. Gegründet 1999 in der Schweiz, ist Medacta in den Bereichen Gelenkersatz, Wirbelsäulenchirurgie und Sportmedizin tätig. Medacta setzt sich für die Verbesserung der Versorgung und des Wohlbefindens von Patienten ein und legt einen starken Fokus auf die Nachhaltigkeit im Gesundheitswesen. Die Innovationen von Medacta, die in enger Zusammenarbeit mit führenden Chirurgen weltweit entstanden sind, begannen mit minimal-invasiven Operationstechniken und entwickelten sich zu personalisierten Lösungen für jeden Patienten weiter. Durch das M.O.R.E. Institut unterstützt Medacta Chirurgen mit einem umfassenden und maßgeschneiderten Programm, das der Förderung der medizinischen Ausbildung dient. Medacta hat seinen Hauptsitz in Castel San Pietro, Schweiz, und ist in über 40 Ländern tätig.

NAICS: 339
NAICS Definition:
Employees: 0
Subsidiaries: 7
12-month incidents
0
Known data breaches
0
Attack type number
0

STERIS

5960 Heisley Rd, Mentor, OH, 44060, US
Last Update: 2025-05-06 (UTC)
Between 750 and 799

STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 10,167
Subsidiaries: 9
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/defaultcompany.jpeg
Medacta Germany
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/steris-corporation.jpeg
STERIS
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Medacta Germany
100%
Compliance Rate
0/4 Standards Verified
STERIS
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Medacta Germany in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for STERIS in 2025.

Incident History — Medacta Germany (X = Date, Y = Severity)

Medacta Germany cyber incidents detection timeline including parent company and subsidiaries

Incident History — STERIS (X = Date, Y = Severity)

STERIS cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/defaultcompany.jpeg
Medacta Germany
Incidents

No Incident

https://images.rankiteo.com/companyimages/steris-corporation.jpeg
STERIS
Incidents

No Incident

FAQ

STERIS company demonstrates a stronger AI Cybersecurity Score compared to Medacta Germany company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, STERIS company has disclosed a higher number of cyber incidents compared to Medacta Germany company.

In the current year, STERIS company and Medacta Germany company have not reported any cyber incidents.

Neither STERIS company nor Medacta Germany company has reported experiencing a ransomware attack publicly.

Neither STERIS company nor Medacta Germany company has reported experiencing a data breach publicly.

Neither STERIS company nor Medacta Germany company has reported experiencing targeted cyberattacks publicly.

Neither Medacta Germany company nor STERIS company has reported experiencing or disclosing vulnerabilities publicly.

Neither Medacta Germany nor STERIS holds any compliance certifications.

Neither company holds any compliance certifications.

STERIS company has more subsidiaries worldwide compared to Medacta Germany company.

STERIS company employs more people globally than Medacta Germany company, reflecting its scale as a Medical Equipment Manufacturing.

Neither Medacta Germany nor STERIS holds SOC 2 Type 1 certification.

Neither Medacta Germany nor STERIS holds SOC 2 Type 2 certification.

Neither Medacta Germany nor STERIS holds ISO 27001 certification.

Neither Medacta Germany nor STERIS holds PCI DSS certification.

Neither Medacta Germany nor STERIS holds HIPAA certification.

Neither Medacta Germany nor STERIS holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

The Bold Page Builder plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the ‘percentage’ parameter in all versions up to, and including, 5.4.5 due to insufficient input sanitization and output escaping. This makes it possible for authenticated attackers, with Contributor-level access and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.

Risk Information
cvss3
Base: 6.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:N
Description

The ComboServlet in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0 through 2023.Q4.2, 2023.Q3.1 through 2023.Q3.5, 7.4 GA through update 92, 7.3 GA through update 35, and older unsupported versions does not limit the number or size of the files it will combine, which allows remote attackers to create very large responses that lead to a denial of service attack via the URL query string.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and create arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary files on the target machine.

Risk Information
cvss3
Base: 7.5
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:H
cvss4
Base: 8.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:H/SC:N/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X